Gastric antral vascular ectasia (GAVE) and hereditary hemorrhagic telangiectasia (HHT): two different conditions, one treatment
- 30 Downloads
Vascular lesions of the digestive tract are among the most frequent causes of gastrointestinal bleeding and iron-deficiency anemia. We write concerning a particular entity—gastric antral vascular ectasia (GAVE)—which is endoscopically characterized by parallel red stripes, angiomatous lesions at the antral mucosal folds, frequently referred to as watermelon stomach. Besides this typical location, it may rarely be found in the cardia, duodenum, jejunum, and rectum. The pathogenesis of this entity is still obscure. However, it is associated with certain comorbidities, such as autoimmune disease, liver cirrhosis, or chronic renal failure [1, 2].
In patients with active hemorrhage or anemia due to chronic bleeding from GAVE, the available evidence favors endoscopic therapy with argon plasma coagulation (APC) or Nd:YAG. Several medical strategies to reduce GI bleeding have been described, namely hormonal therapy, octreotide, tranexamic acid, thalidomide, or prednisolone, none...
Compliance with ethical standards
Conflict of interest
The authors declare that they have no conflict of interest.
All procedures performed in studies involving human participants were in accordance with the ethical standards of the institutional and/or national research committee and with the 1964 Helsinki declaration and its later amendments or comparable ethical standards.
Informed consent was obtained from all individual participants included in the study.
- 1.Hsu WH, Wang YK, Hsieh MS, et al.: Insights into the management of gastric antral vascular ectasia (watermelon stomach), Therap Adv Gastroenterol. 2018; 14;11:1756283X17747471Google Scholar